Two Sigma Securities, LLC Bluebird Bio, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $84,749 - $124,701	14,688 New	14,688 $101,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $181,288 - $440,055	-6,930 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $243,018 - $319,142	5,175 Added 294.87%	6,930 $608,000
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $107,614 - $173,863	-1,670 Reduced 48.76%	1,755 $276,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $202,417 - $319,415	3,425 New	3,425 $340,000

42.6M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.